You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華瑞股份(300626.SZ):參股公司康澤藥業已進入上市輔導階段
格隆匯 01-27 16:08

格隆匯1月27日丨華瑞股份(300626.SZ)公佈,公司獲悉參股公司康澤藥業股份有限公司(“康澤藥業)向中國證券監督管理委員會廣東監管局(廣東證監局)提交的向不特定合格投資者公開發行股票並在北京證券交易所(北交所)上市的輔導備案資料獲得受理並於2022125日收到書面確認文件,輔導機構為粵開證券股份有限公司。

截至公吿披露日,公司持有康澤藥業15%的股份。

康澤藥業已進入上市輔導階段。康澤藥業公開發行股票並在北交所上市的申請存在無法通過北交所發行上市審核或中國證監會註冊的風險,存在因公開發行失敗而無法在北交所上市的風險。公司將根據事項進展情況,嚴格按照相關法律法規的規定及時履行信息披露義務

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account